Список литературы

1. Becker A.E., Connor M., Anderson R.H. Tetralogy of Fallot a. Morphometric and geometric study. Am. J. Cardiol. 1975; 35: 402-12.

2. Бокерия Л.А., Шаталов К.В. Детская кардиохирургия // М., 2016.

3. Anderson R.H., Wilkinson J.L., Arnold R. et al. Morphogenesis of bulboventricular malformations. Consideration of embryogenesis in the normal heart // Brit. Heart J. - 1974. - Vol.36. - P. 242 - 255.

4. Kirklin J.W., Barratt-Boyes B.G. Cardiac surgery: Morphology, diagnostic criteria, natural history, techniques, results, and indications. 4rd ed. N.Y.; 2013.

5. Бураковский В.И., Бокерия Л.А. //Сердечно-сосудистая хирургия // М., 1996.

6. Haas N.A., Schirmer K.R. Guidelines for the Management of congenital heart diseases in Childhood and adolescence. // Cardiolodgy in the young. 2017. 27 (suppl. 3), S. 1 - 105.

7. Habib G., Lancellotti P., Antunes M.J. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J Volume 36, Issue 44, 21 November 2015, Pages 3075 - 3128.

8. Giglia T., Massicotte M., Tweddell J. et al. Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation.2013; 128:2622 - 2703.

9. Gatzoulis M.A., Balaji S., Webber S.A. et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000; 356: 975-81.

10. Marshall L.J. Congenital Heart Surgery Nomenclature and Database Project: Tetralogy of Fallot, Ann Thorac Surg 2000; 69: 77 - 82.

11. Чебан В.Н. Врожденное отсутствие клапана легочной артерии. Грудная хирургия. 1987. N 3. С. 73 - 78.

12. Kogon B.E., et al. Current Readings: Issues Surrounding Pulmonary Valve Replacement in Repaired Tetralogy of Fallot. Semin Thorac Cardiovasc Surg. 2015. PMID: 26074110 Review.

13. Национальные рекомендации по ведению детей с врожденными пороками сердца. Ред. Л.А. Бокерия. М., 2014.

14. Perloff J.K. Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism. Cardiol Clin 1993; 11: 689 - 699.

15. Фальковский Г.Э., Крупянко С.М. Сердце ребенка: книга для родителей о врожденных пороках сердца. - М.: Никея, 2011.

16. Подзолков В.П., Кокшенев И.В. Тетрада Фалло. М.: НЦССХ им. А.Н. Бакулева РАМН; 2008.

17. Baumgartner H., De Backer J., Babu-Narayan S.V. et al. 2020 ESC Guidelines for themanagement of adult congenital heart disease. The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC)//European Heart Journal (2020) 00, 1 - 83.

18. Wise-Faberowski L., Asija R., McElhinney D.B. Tetralogy of Fallot: Everything you wanted to know but were afraid to ask. Paediatr Anaesth. 2019 May; 29(5): 475 - 482.

19. Mauritz G.J., Rizopoulos D., Groepenhoff H. et al. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension. Am J Cardiol. 2011. 108(11): 1645-50.

20. Mavroudis C. Pediatric cardiac surgery. Mosby; 2012.

21. Mcleod G, Shum K, Gupta T, Chakravorty S, Kachur S, Bienvenu L, White M, Shah SB. Echocardiography in Congenital Heart Disease. Prog Cardiovasc Dis. 2018 Nov - Dec; 61(5 - 6): 468 - 475.

22. Huntgeburth M, Germund I, Geerdink LM, Sreeram N, Udink Ten Cate FEA. Emerging clinical applications of strain imaging and three-dimensional echocardiography for the assessment of ventricular function in adult congenital heart disease. Cardiovasc Diagn Ther. 2019 Oct; 9 (Suppl 2): S326 - S345.

23. Sharkey AM, Sharma A. Tetralogy of Fallot: anatomic variants and their impact on surgical management. Semin Cardiothorac Vasc Anesth. 2012 Jun; 16(2): 88 - 96.

24. Алекян Б.Г. Рентгенэндоваскулярная хирургия. Национальное руководство в 4-х томах // Под ред. Алекяна Б.Г. Издательство "Литтерра". 2017.

25. Townsley MM, Windsor J, Briston D, Alegria J, Ramakrishna H. Tetralogy of Fallot: Perioperative Management and Analysis of Outcomes. J Cardiothorac Vasc Anesth. 2019 Feb; 33(2): 556 - 565.

26. Timothy F. Feltes, Emile Bacha, Robert H. Beekman, John P. Cheatham, Jeffrey A. Feinstein, Antoinette S. Gomes, Ziyad M. Hijazi et al. Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac disease: a scientific statement from the American Heart Association. // Circulation 2011; 123 (22): 2607-52.

27. Apostolopoulou SC, Manginas A, Kelekis NL, Noutsias M. Cardiovascular imaging approach in pre and postoperative tetralogy of Fallot. BMC Cardiovasc Disord. 2019 Jan 07; 19(1):7.

28. Ojha V, Pandey NN, Sharma A, Ganga KP. Spectrum of changes on cardiac magnetic resonance in repaired tetralogy of Fallot: Imaging according to surgical considerations. Clin Imaging. 2021 Jan; 69: 102 - 114.

29. Ho AB, Bharucha T, Jones E, Thuraisingham J, Kaarne M, Viola N. Primary surgical repair of tetralogy of Fallot at under three months of age. Asian Cardiovasc Thorac Ann. 2018 Sep; 26(7): 529 - 534.

30. Kirklin J.W., Bargeron L.M.J., Pacifico A.D. et al. Management of the tetralogy of Fallot with large aorto-pulmonary collateral arteries. In: Godman M.J. (ed.). Pediatric cardiology. Edinburg: Churchill Livingstone. 1981; 4: 483-91.

31. Ergun S, Gen SB, Yildiz O, Ozturk E, Gunes M, Onan S, Guzelta A, Haydin S. Predictors of a complicated course after surgical repair of tetralogy of Fallot. Turk Gogus Kalp Damar Cerrahisi Derg. 2020 Apr 22; 28(2): 264 - 273.

32. Egbe AC, Uppu SC, Mittnacht AJ, Joashi U, Ho D, Nguyen K, Srivastava S. Primary tetralogy of Fallot repair: predictors of intensive care unit morbidity. Asian Cardiovasc Thorac Ann. 2014 Sep; 22(7): 794-9.

33. Khan SM, Drury NE, Stickley J, Barron DJ, Brawn WJ, Jones TJ, Anderson RH, Crucean A. Tetralogy of Fallot: morphological variations and implications for surgical repair. Eur J Cardiothorac Surg. 2019 Jul 01; 56(1): 101 - 109.

34. Tworetzky W., McElhinney D.B., Brook M.M., Reddy V.M., Hanley F.L., Silverman N.H. Echocardiographic diagnosis alone for the complete repair of major congenital heart defects. J Am Coll Cardiol. 1999 Jan; 33(1): 228-33. doi: 10.1016/s0735-1097(98) 00518-x.

35. Рыбка М.М., Хинчагов Д.Я., Мумладзе К.В., Лобачева Г.В., Ведерникова Л.В. Под ред. Л.А. Бокерия. Протоколы анестезиологического обеспечения кардиохирургических операций, выполняемых у новорожденных и детей. Методические рекомендации. М.: НЦССХ им. А.Н. Бакулева РАМН; 2014.

36. Рыбка М.М., Хинчагов Д.Я. Под ред. Л.А. Бокерия. Протоколы анестезиологического обеспечения кардиохирургических операций, выполняемых при ишемической болезни сердца, патологии клапанного аппарата, нарушениях ритма, гипертрофической кардиомиопатии, аневризмах восходящего отдела аорты у пациентов различных возрастных групп. Методические рекомендации. М.: НЦССХ им. А.Н. Бакулева РАМН; 2015.

37. Рыбка М.М., Хинчагов Д.Я., Мумладзе К.В., Никулкина Е.С. Под ред. Л.А. Бокерия. Протоколы анестезиологического обеспечения рентгенэндоваскулярных и диагностических процедур, выполняемых у кардиохирургических пациентов различных возрастных групп. Методические рекомендации. М.: НЦССХ им. А.Н. Бакулева РАМН; 2018.

38. Marino P.L. ред. А.И. Мартынов. Интенсивная терапия (перевод с англ.). ГЭОТАР Медицина. Москва. 1998

39. Twite MD, Ing RJ. Tetralogy of Fallot: perioperative anesthetic management of children and adults. Semin Cardiothorac Vasc Anesth. 2012 Jun; 16(2): 97 - 105.

40. Подзолков В.П., Алекян Б.Г., Кокшенев И.В., Чебан В.Н. Повторные операции после коррекции врожденных пороков сердца. М.: НЦССХ им. А.Н. Бакулева РАМН; 2013.

41. Подзолков В.П., Кассирский Г.И. (ред.). Реабилитация больных после хирургического лечения врожденных пороков сердца. М.: НЦССХ им. А.Н. Бакулева; 2015.

42. Van Straten A., Vliegen H.W., Hazekamp M.G., de Roos A. Right ventricular function late after total repair of tetralogy of Fallot. Eur. Radiol. 2005; 15: 702-7.

43. Priori S.G., Blomstrom-Lundqvist C., Mazzanti A. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). ESC Scientific Document Group. Eur Heart J. 2015 Nov 1; 36 (41): 2793 - 2867.

44. Brugada J., Blom N., Sarquella-Brugada G. et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. European Heart Rhythm Association; Association for European Paediatric and Congenital Cardiology. 2013 Sep; 15 (9): 1337-82.

45. Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanoticcongenital heart disease. J Am Coll Cardiol 1996; 28: 768 - 772.

46. Senthilnathan S, Dragulescu A, Mertens L. Pulmonary Regurgitation after Tetralogy of Fallot Repair: A Diagnostic and Therapeutic Challenge. J Cardiovasc Echogr. 2013 Jan-Mar; 23(1): 1 - 9.

47. Forman J, Beech R, Slugantz L, Donnellan A. A Review of Tetralogy of Fallot and Postoperative Management. Crit Care Nurs Clin North Am. 2019 Sep; 31(3): 315 - 328.

48. Promphan W, et al. A comparative study: right ventricular assessment in post-repaired tetralogy of Fallot patients by echocardiogram with cardiac magnetic resonance imaging. J Med Assoc Thai. 2014. 2014 Jun; 97 Suppl 6: S232-8.

49. Latus H, Hachmann P, Gummel K, Khalil M, Yerebakan C, Bauer J, Schranz D, Apitz C. Impact of residual right ventricular outflow tract obstruction on biventricular strain and synchrony in patients after repair of tetralogy of Fallot: a cardiac magnetic resonance feature tracking study. Eur J Cardiothorac Surg. 2015 Jul; 48(1): 83 - 90.

50. Stark J., deLeval M., Tsang V.T. Surgery for congenital heart defects. John Wiley, Sons, Ltd; 2006.

51. Hoffman JI, Kaplan S. //The incidence of congenital heart disease. //J Am Coll Cardiol. 2002; 39: 1890-900.

52. Krieger EV, Valente AM. Tetralogy of Fallot. Cardiol Clin. 2020 Aug; 38(3): 365 - 377.

53. Plana M.N. et al. Pulse oximetry screening for critical congenital heart defects //Cochrane Database of systematic reviews. - 2018. - N. 3.

54. Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Schreier J, Gatzoulis MA, Groenink M, Inuzuka R, Kilner PJ, Koyak Z, Landzberg MJ, Mulder B, Powell AJ, Wald R, Geva T. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014; 100(3): 247-53.

55. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022; 24(1): 4 - 131.

56. Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, Khan M, Ho SY, Pennell DJ, Gatzoulis MA. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 2006; 113: 405 - 413

57. Maurer SJ, Pujol Salvador C, Schiele S, Hager A, Ewert P, Tutarel O. Sacubitril/valsartan for heart failure in adults with complex congenital heart disease. Int J Cardiol 2020; 300: 137 - 140.

58. Miller JR, Stephens EH, Goldstone AB, Glatz AC, Kane L, Van Arsdell GS, Stellin G, Barron DJ, d"Udekem Y, Benson L, Quintessenza J, Ohye RG, Talwar S, Fremes SE, Emani SM, Eghtesady P. The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: Management of infants and neonates with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2023; 165(1): 221 - 250.

59. Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Schreier J, Gatzoulis MA, Groenink M, Inuzuka R, Kilner PJ, Koyak Z, Landzberg MJ, Mulder B, Powell AJ, Wald R, Geva T. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014 Feb; 100(3): 247-53. doi: 10.1136/heartjnl-2013-304958.

60. Svobodov A.A., Kupryashov A.A., Dobroserdova T.K., Levchenko E.G., Tumanyan M.R., Anderson A.G. A new approach to the interpretation of B-type natriuretic peptide concentration in children with congenital heart disease. Journal of Laboratory Medicine, 2023; 47(5): 225 - 232.

61. Saraya, S., Ramadan, A., AbdelMassih, A. et al. Arrhythmias in repaired pediatric and adolescent Fallot tetralogy, correlation with cardiac MRI parameters. Egypt J Radiol Nucl Med 52, 213 (2021).

62. Krieger EV, Zeppenfeld K, DeWitt ES, Duarte VE, Egbe AC, Haeffele C, Lin KY, Robinson MR, Sillman C, Upadhyay S; American Heart Association Adults With Congenital Heart Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young and Council on Clinical Cardiology. Arrhythmias in Repaired Tetralogy of Fallot: A Scientific Statement From the American Heart Association. Circ Arrhythm Electrophysiol. 2022 Nov; 15(11):e000084.

63. Sabate Rotes A, Connolly HM, Warnes CA, Ammash NM, Phillips SD, Dearani JA, Schaff HV, Burkhart HM, Hodge DO, Asirvatham SJ, McLeod CJ. Ventricular arrhythmia risk stratification in patients with tetralogy of Fallot at the time of pulmonary valve replacement. Circ Arrhythm Electrophysiol. 2015 Feb; 8(1): 110-6.

64. Karen K, Daniels CJ, Aboulhosn J, Bozkurt B, Broberg C, Colman J, Crumb S, Dearani J, Fuller S, Gurvitz M, Khairy P, Landzberg M, Saidi A, Valente A, Van Hare G (2018) AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation 2019(139): e698 - e800.

65. Le Gloan L, Khairy P. Management of arrhythmias in patients with tetralogy of Fallot. Curr Opin Cardiol. 2011 Jan; 26(1): 60-5.

66. Rivas-Gandara N, Francisco-Pascual J, Pijuan-Domenech A, Ribera-Sole A, Dos-Subira L, Benito B, Terricabras M, Perez-Rodon J, Subirana MT, Santos-Ortega A, Roses-Noguer F, Miranda B, Moya-Mitjans A, Ferreira-Gonzalez I. Risk stratification of ventricular arrhythmias in repaired tetralogy of Fallot. Rev Esp Cardiol (Engl Ed). 2021 Nov; 74(11): 935 - 942. English, Spanish.

67. Shade JK, Cartoski MJ, Nikolov P, Prakosa A, Doshi A, Binka E, Olivieri L, Boyle PM, Spevak PJ, Trayanova NA. Ventricular arrhythmia risk prediction in repaired Tetralogy of Fallot using personalized computational cardiac models. Heart Rhythm. 2020 Mar; 17(3): 408 - 414.

68. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 23: e143 - 263.

69. Saxena A, Relan J, Agarwal R, Awasthy N, Azad S, Chakrabarty M. et all. Indian guidelines for indications and timing of intervention for common congenital heart diseases: Revised and updated consensus statement of the Working group on management of congenital heart diseases. Ann Pediatr Cardiol. 2019 Sep-Dec; 12(3): 254 - 286.

70. Akkinapally S, Hundalani SG, Kulkarni M, et al. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions. Cochrane Database Syst Rev 2018; 2: CD011417.

71. Vari D, Xiao W, Behere S, Spurrier E, Tsuda T, Baffa JM. Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines? Cardiol Young. 2021 Jan; 31(1): 63 - 70.

72. Yucel IK, Cevik A, Bulut MO, Dedeoglu R, Demir IH, Erdem A, Celebi A. Efficacy of very low-dose prostaglandin E1 in duct-dependent congenital heart disease. Cardiol Young. 2015 Jan; 25(1): 56 - 62.

73. Expert Consensus Panel:; Miller JR, Stephens EH, Goldstone AB, Glatz AC, Kane L, Van Arsdell GS, Stellin G, Barron DJ, d"Udekem Y, Benson L, Quintessenza J, Ohye RG, Talwar S, Fremes SE, Emani SM, Eghtesady P. The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: Management of infants and neonates with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2023 Jan; 165(1): 221 - 250.

74. Ganigara M, Sagiv E, Buddhe S, Bhat A, Chikkabyrappa SM. Tetralogy of Fallot With Pulmonary Atresia: Anatomy, Physiology, Imaging, and Perioperative Management. Semin Cardiothorac Vasc Anesth. 2021 Sep; 25(3): 208 - 217.

75. Book WM, Shaddy RE. Medical therapy in adults with congenital heart disease. Heart Fail Clin. 2014 Jan; 10(1): 167-78.

76. Holst KA, Dearani JA, Burkhart HM, Connolly HM, Warnes CA, Li Z, Schaff HV. Risk factors and early outcomes of multiple reoperations in adults with congenital heart disease. Ann Thorac Surg. 2011 Jul; 92(1): 122-8; discussion 129-30.

77. Dinardo JA. Heart failure associated with adult congenital heart disease. Semin Cardiothorac Vasc Anesth. 2013 Mar; 17(1): 44 - 54.

78. Shaddy RE, Webb G. Applying heart failure guidelines to adult congenital heart disease patients. Expert Rev Cardiovasc Ther. 2008 Feb; 6(2): 165-74.

79. Groh WJ, Foreman LD, Zipes DP. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators. Am Fam Physician. 1998 Jan 15; 57(2): 297 - 307, 310-2.

80. Wilkoff BL; Dual Chamber and VVI Implantable Defibrillator trial investigators. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Card Electrophysiol Rev. 2003 Dec; 7(4): 468-72.

81. Valdigem BP, Moreira DAR, Andalaft RB, Santana MVT, Sierra-Reyes CA, Mizzacci C. Successful Treatment of Ventricular Arrhythmia in Tetralogy of Fallot Repair Using Catheter Ablation. Braz J Cardiovasc Surg. 2018 Jul-Aug; 33(4): 418 - 423.

82. Caldaroni F, Lo Rito M, Chessa M, Varrica A, Micheletti A, Pappone C, Giamberti A. Surgical ablation of ventricular tachycardia in patients with repaired tetralogy of Fallot. Eur J Cardiothorac Surg. 2019 May 1; 55(5): 845 - 850.

83. Walsh EP. The role of ablation therapy for ventricular tachycardia in patients with tetralogy of Fallot. Heart Rhythm. 2018 May; 15(5): 686 - 687.

84. Abbaszadeh R, Askari-Moghadam R, Moradian M, Mortazaeian H, Qomi MRS, Omidi N, Khalili Y, Tahouri T. The Nakata index and McGoon ratio: correlation with the severity of pulmonary regurgitation after the repair of paediatric tetralogy of Fallot. Egypt Heart J. 2023 Nov 29; 75(1): 95.

85. Caspi J, Zalstein E, Zucker N, Applebaum A, Harrison LH Jr, Munfakh NA, Heck HA Jr, Ferguson TB Jr, Stopa A, White M, Fontenot EE. Surgical management of tetralogy of Fallot in the first year of life. Ann Thorac Surg. 1999 Oct; 68(4): 1344-8; discussion 1348-9.

86. Rossi RN, Hislop A, Anderson RH, Martins FM, Cook AC. Systemic-to-pulmonary blood supply in Tetralogy of Fallot with pulmonary atresia. Cardiol Young. 2002 Jul; 12(4): 373-88.

87. Laurentius A, Wiyono L, Dominique Subali A, Natalia Siagian S. Evaluation of Right Ventricular Outflow Tract Stenting as Palliative Treatment in Severely Cyanotic Tetralogy of Fallot: A Systematic Review and Meta-Analysis of Observational Studies. J Tehran Heart Cent. 2021 Oct; 16(4): 135 - 146.

88. Siddiqi U, Adewale A, Pena E, Schulz K, Ilbawi M, El-Zein C, Vricella L, Hibino N. Preserving the pulmonary valve in Tetralogy of Fallot repair: Reconsidering the indication for valve-sparing. J Card Surg. 2022 Dec; 37(12): 5144 - 5152.

89. Sinha R, Gooty V, Jang S, Dodge-Khatami A, Salazar J. Validity of Pulmonary Valve Z-Scores in Predicting Valve-Sparing Tetralogy Repairs-Systematic Review. Children (Basel). 2019 May 4; 6(5): 67.

90. Petit CJ, Glatz AC, Goldstone AB, Law MA, Romano JC, Maskatia SA, Chai PJ, Zampi JD, Meadows JJ, Nicholson GT, Shahanavaz S, Qureshi AM, McCracken CE, Mascio CE, Batlivala SP, Asztalos IB, Healan SJ, Smith JD, Pettus JA, Beshish A, Raulston JEB, Hock KM, Pajk AL, Goldstein BH. Pulmonary Artery Hypoplasia in Neonates With Tetralogy of Fallot. J Am Coll Cardiol. 2023 Aug 15; 82(7): 615 - 627.

91. Goldstein BH, Petit CJ, Qureshi AM, McCracken CE, Kelleman MS, Nicholson GT, Law MA, Meadows JJ, Zampi JD, Shahanavaz S, Mascio CE, Chai PJ, Romano JC, Batlivala SP, Maskatia SA, Asztalos IB, Kamsheh AM, Healan SJ, Smith JD, Ligon RA, Pettus JA, Juma S, Raulston JEB, Hock KM, Pajk AL, Eilers LF, Khan HQ, Merritt TC, Canter M, Juergensen S, Rinderknecht FA, Bauser-Heaton H, Glatz AC. Comparison of Management Strategies for Neonates With Symptomatic Tetralogy of Fallot. J Am Coll Cardiol. 2021 Mar 2; 77(8): 1093 - 1106.

92. Bauser-Heaton H, Borquez A, Asija R, Wise-Faberowski L, Zhang Y, Downey L, Perry SB, Koth A, Peng LF, Algaze CA, Hanley FL, McElhinney DB. Pulmonary reinterventions after complete unifocalization and repair in infants and young children with tetralogy of Fallot with major aortopulmonary collaterals. J Thorac Cardiovasc Surg. 2018 Apr; 155(4): 1696 - 1707.

93. Grosse-Wortmann L, Yoo SJ, van Arsdell G, Chetan D, Macdonald C, Benson L, Honjo O. Preoperative total pulmonary blood flow predicts right ventricular pressure in patients early after complete repair of tetralogy of Fallot and pulmonary atresia with major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg. 2013 Nov; 146(5): 1185-90.

94. Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Gottl U, Vesely SK. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl): e737S - e801S. doi: 10.1378/chest.11-2308.

95. Купряшов А.А., Токмакова К.А. Нарушения системы свертывания крови в сердечно-сосудистой хирургии. В кн.: Система гемостаза. Теоретические основы и клиническая практика: Национальное руководство/О.А. Рукавицын, С.В. Игнатьев, А.Г. Румянцев [и др.]. Москва: Общество с ограниченной ответственностью Издательская группа "ГЭОТАР-Медиа", 2024. 944 с. ISBN 978-5-9704-8497-5.

96. Приказ Минздрава РФ от 20 октября 2020 г. N 1134н "Об утверждении порядка медицинского обследования реципиента, проведения проб на индивидуальную совместимость, включая биологическую пробу, при трансфузии донорской крови и (или) ее компонентов"

97. Аксельрод Б.А., Балашова Е.Н., Баутин А.Е., Баховадинов Б.Б., Бирюкова Л.С., Буланов А.Ю., Быстрых О.А., Виноградова М.А., Галстян Г.М., Гапонова Т.В., Головкина Л.Л., Гороховский В.С., Еременко А.А., Жибурт Е.Б., Журавель С.В., Кохно А.В., Кузьмина Л.А., Кулабухов В.В., Купряшов А.А., Лубнин А.Ю., Мазурок В.А., Меньшугин И.Н., Минеева Н.В., Михайлова Е.А., Никитин Е.А., Оловникова Н.И., Ошоров А.В., Певцов Д.Э., Попцов В.Н., Рогачевский О.В., Салимов Э.Л., Титков К.В., Трахтман П.Е., Троицкая В.В., Федорова Т.А., Фидарова З.Т., Цветаева Н.В., Чжао А.В., Шестаков Е.Ф. Клиническое использование эритроцитсодержащих компонентов донорской крови. Гематология и трансфузиология. 2018; 63(4): 372 - 435.

98. Постановление Главного государственного санитарного врача РФ от 28 января 2021 г. N 4 "Об утверждении санитарных правил и норм СанПиН 3.3686-21 "Санитарно-эпидемиологические требования по профилактике инфекционных болезней".

99. Купряшов А.А. Бережное отношение к крови пациента. В кн.: Система гемостаза. Теоретические основы и клиническая практика: Национальное руководство/О.А. Рукавицын, С.В. Игнатьев, А.Г. Румянцев [и др.]. - Москва: Общество с ограниченной ответственностью Издательская группа "ГЭОТАР-Медиа", 2024. - 944 с. - ISBN 978-5-9704-8497-5. - DOI 10.33029/9704-8497-5-THS-2024-1-944.